Synapse - Martin Tallman

Results (88)

Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition

Journal Article

Cai, S. F.; Chu, S. H.; Goldberg, A. D.; Parvin, S.; Koche, R. P.; Glass, J. L.; Stein, E. M.; Tallman, M. S.; Sen, F.; Famulare, C. A.; more...
Cancer Discovery (2020)

Fulltext@MSK | Save

Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes

Journal Article

Menghrajani, K.; Zhang, Y.; Famulare, C.; Devlin, S. M.; Tallman, M. S.
Leukemia Research (2020)

Fulltext@MSK | Save

Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure

Journal Article

Ball, B. J.; Famulare, C. A.; Stein, E. M.; Tallman, M. S.; Derkach, A.; Roshal, M.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; more...
Blood Advances (2020)

Fulltext@MSK | Save

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: A single-centre, single-arm, phase 2 trial

Journal Article

Taylor, J.; Mi, X.; Penson, A. V.; Paffenholz, S. V.; Alvarez, K.; Sigler, A.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; more...
The Lancet Haematology (2020)

Fulltext@MSK | Save

Erythroid/megakaryoblastic leukemia with TP53 and RUNX1 mutations frequently occurs in blast transformation of Philadelphia chromosome-negative myeloproliferative neoplasms: A single-institution experience with 56 cases

Meeting Abstract

Liu, Y.; Mata, D.; Baik, J.; Famulare, C.; Sigler, A.; Arcila, M.; Zhang, Y.; Dogan, A.; Tallman, M.; Levine, R.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

Frequent RUNX1 and TP53 mutations in secondary acute myeloid leukemia with mixed phenotype

Meeting Abstract

Galera, P.; Baik, J.; Famulare, C.; Sigler, A.; Zhang, Y.; Arcila, M.; Dogan, A.; Tallman, M.; Levine, R.; Glass, J.; more...
Laboratory Investigation (2020)

Fulltext@MSK | Save

MLL-rearranged AML is associated with poor outcomes as compared to patients with intermediate- and adverse-risk disease: A CIBMTR study of 3779 adult patients

Meeting Abstract

Menghrajani, K.; Zhang, M. J.; Bo-Subait, K.; Wang, H. L.; Devlin, S. M.; Madero-Marroquin, R.; Gomez Arteaga, A.; Sandmaier, B. M.; Litzow, M. R.; Kebriaei, P.; more...
Biology of Blood and Marrow Transplantation (2020)

Fulltext@MSK | Save

Acute leukemia with lineage infidelity: Mixed phenotype AML exhibits a distinct immunophenotype with clinical features overlapping mixed phenotype acute leukemia